In our study, FBP1 was downregulated in the tissues of ccRCC patients, suggesting that glycolysis was enhanced in ccRCC, while gluconeogenesis was decreased, which was consistent with our expectations. This evidence concerns the gene FBP1 and nonpapillary renal cell carcinoma.